Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing …
…, VR Polonis, M Koutsoukos, G Voss… - Journal of …, 2005 - Am Soc Microbiol
Induction of broadly cross-reactive neutralizing antibodies is a high priority for AIDS vaccine
development but one that has proven difficult to be achieved. While most immunogens …
development but one that has proven difficult to be achieved. While most immunogens …
Efficacy of RTS, S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial
…, P Gothard, L Yamuah, M Delchambre, G Voss… - The Lancet, 2001 - thelancet.com
Background RTS,S/AS02 is a pre-erythrocytic malaria vaccine based on the circumsporozoite
surface protein of Plasmodium falciparum fused to HBsAg, incorporating a new adjuvant (…
surface protein of Plasmodium falciparum fused to HBsAg, incorporating a new adjuvant (…
Efficacy of Recombinant Circumsporozoite Protein Vaccine Regimens against Experimental Plasmodium falciparum Malaria
…, T Hall, U Krzych, M Delchambre, G Voss… - The Journal of …, 2001 - academic.oup.com
After initial successful evaluation of the circumsporozoite-based vaccine RTS,S/SBAS2,
developed by SmithKline Beecham Biologicals with the Walter Reed Army Institute of Research, …
developed by SmithKline Beecham Biologicals with the Walter Reed Army Institute of Research, …
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys
…, HW Virgin, M Koutsoukos, C Lorin, G Voss… - Science, 2015 - science.org
Preclinical studies of viral vector–based HIV-1 vaccine candidates have previously shown
partial protection against neutralization-resistant virus challenges in rhesus monkeys. In this …
partial protection against neutralization-resistant virus challenges in rhesus monkeys. In this …
A CD4+ T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and …
…, P Akinwunmi, S Everaere, KR Watkins, G Voss… - Nature medicine, 2004 - nature.com
Many human T-cell responses specific for epitopes in Plasmodium falciparum have been
described, but none has yet been shown to be predictive of protection against natural malaria …
described, but none has yet been shown to be predictive of protection against natural malaria …
Protective immunity induced with malaria vaccine, RTS, S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN …
…, JA Stoute, J Cohen, WR Ballou, G Voss… - The Journal of …, 2003 - journals.aai.org
The Plasmodium falciparum circumsporozoite (CS) protein-based pre-erythrocytic stage
vaccine, RTS, S, induces a high level of protection against experimental sporozoite challenge. …
vaccine, RTS, S, induces a high level of protection against experimental sporozoite challenge. …
Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated
…, BB Simen, B Hanczaruk, AZ Fire, G Voss… - Journal of Experimental …, 2011 - rupress.org
The initial antibody response to HIV-1 is targeted to envelope (Env) gp41, and is nonneutralizing
and ineffective in controlling viremia. To understand the origins and characteristics of …
and ineffective in controlling viremia. To understand the origins and characteristics of …
An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model
JR Putnak, BA Coller, G Voss, DW Vaughn… - Vaccine, 2005 - Elsevier
The safety, immunogenicity, and protective efficacy of two non-replicating antigen-based
vaccines and one live-attenuated virus (LAV) vaccine for dengue type-2 (dengue-2) virus were …
vaccines and one live-attenuated virus (LAV) vaccine for dengue type-2 (dengue-2) virus were …
An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human …
KA Reimann, JT Li, G Voss, C Lekutis… - Journal of …, 1996 - Am Soc Microbiol
To explore the roles played by specific human immunodeficiency virus type 1 (HIV-1) genes
in determining the in vivo replicative capacity of AIDS viruses, we have examined the …
in determining the in vivo replicative capacity of AIDS viruses, we have examined the …
Potent induction of focused Th1-type cellular and humoral immune responses by RTS, S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine
A Lalvani, P Moris, G Voss, AA Pathan… - The Journal of …, 1999 - academic.oup.com
The RTS,S/SBAS2 vaccine confers sterile protection against Plasmodium falciparum sporozoite
challenge. The mechanisms underlying this are of great interest, yet little is known about …
challenge. The mechanisms underlying this are of great interest, yet little is known about …